NAVEENA, T. Empagliflozin: a wonder drug in preventing diabetic nephropathy and cardiovascular effects. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 5, n. 5, p. 1704–1707, 2017. DOI: 10.18203/2319-2003.ijbcp20163202. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/490. Acesso em: 16 apr. 2026.